1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope/Limitations
2.3. Inclusion & Exclusion
3. Key Market Trends
3.1. Key Trends Impacting The Market
3.2. Innovation/Development Trends
4. Value added Insights
4.1. Regulatory Scenario
4.2. Key Promotional Strategies by Service Provider
4.3. PESTLE Analysis
4.4. Porter’s Analysis
4.5. Ice-Berg Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Pharmaceutical Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Hormones in Pipeline
5.2.2. Rising Incidence of hormone deficiency and infertility in women
5.2.3. Rapid Growth in Cosmetic Procedures
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. COVID19 and Impact Analysis
6.2.1. By Therapy Type
6.2.2. By Indication
6.2.3. By Dosage Form
6.2.4. By End User
6.2.5. By Country
7. Global Hormone Replacement Therapy Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Hormone Replacement Therapy Market Analysis 2017-2021 and Forecast 2022-2032, by Therapy Type
8.1. Introduction/Key Findings
8.2. Historical Market Size (US$ Mn) Analysis by Therapy Type, 2017-2021
8.3. Current and Future Market Size (US$ Mn) and Forecast by Therapy Type, 2022-2032
8.3.1. Estrogen Replacement Therapy
8.3.2. Testosterone Replacement Therapy
8.3.3. Thyroid Hormone Replacement Therapy
8.3.4. Growth Hormone Replacement Therapy
8.3.5. Progestogen Hormone Replacement Therapy
8.4. Market Attractiveness Analysis by Therapy Type
9. Global Hormone Replacement Therapy Market Analysis 2017-2021 and Forecast 2022-2032, by Indication
9.1. Introduction/Key Findings
9.2. Historical Market Size (US$ Mn) Analysis by Usage, 2017-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Indication, 2022-2032
9.3.1. Menopause
9.3.2. Male Hypogonadism
9.3.3. Hypothyroidism
9.3.4. Growth Hormone Deficiency
9.3.5. Chromosomal disorder
9.3.6. Cancer
9.3.7. Others
9.4. Market Attractiveness Analysis by Indication
10. Global Hormone Replacement Therapy Market Analysis 2017-2021 and Forecast 2022-2032, by Dosage Form
10.1. Introduction/Key Findings
10.2. Historical Market Size (US$ Mn) Analysis by Dosage Form, 2017-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Dosage Form, 2022-2032
10.3.1. Injections
10.3.2. Gels or Creams
10.3.3. Implants
10.3.4. Patches
10.3.5. Oral Tablets/Capsules
10.3.6. Others
10.4. Market Attractiveness Analysis by Dosage Form
11. Global Hormone Replacement Therapy Market Analysis 2017-2021 and Forecast 2022-2032, by End User
11.1. Introduction/Key Findings
11.2. Historical Market Size (US$ Mn) Analysis by End User, 2017-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2022-2032
11.3.1. Hospitals
11.3.2. Specialty Clinics
11.3.3. Ambulatory Care Centers
11.3.4. Others
11.4. Market Attractiveness Analysis by End User
12. Global Hormone Replacement Therapy Market Analysis 2017-2021 and Forecast 2022-2032, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis by Region, 2017-2021
12.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2022-2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. South Asia
12.3.5. East Asia
12.3.6. Oceania
12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis by Region
13. North America Hormone Replacement Therapy Market Analysis 2017-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017-2021
13.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022-2032
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Therapy Type
13.3.3. By Indication
13.3.4. By Dosage Form
13.3.5. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Therapy Type
13.4.3. By Indication
13.4.4. By Dosage Form
13.4.5. By End User
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. Latin America Hormone Replacement Therapy Market 2017-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017-2021
14.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022-2032
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Therapy Type
14.3.3. By Indication
14.3.4. By Dosage Form
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Therapy Type
14.4.3. By Indication
14.4.4. By Dosage Form
14.4.5. By End User
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Europe Hormone Replacement Therapy Market 2017-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017-2021
15.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022-2032
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Therapy Type
15.3.3. By Indication
15.3.4. By Dosage Form
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Therapy Type
15.4.3. By Indication
15.4.4. By Dosage Form
15.4.5. By End User
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. South Asia Hormone Replacement Therapy Market 2017-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017-2021
16.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022-2032
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Therapy Type
16.3.3. By Indication
16.3.4. By Dosage Form
16.3.5. By End User
16.3.6. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Therapy Type
16.4.3. By Indication
16.4.4. By Dosage Form
16.4.5. By End User
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. East Asia Hormone Replacement Therapy Market 2017-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017-2021
17.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022-2032
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Therapy Type
17.3.3. By Indication
17.3.4. By Dosage Form
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Therapy Type
17.4.3. By Indication
17.4.4. By Dosage Form
17.4.5. By End User
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. Oceania Hormone Replacement Therapy Market 2017-2021 and Forecast 2022-2032
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017-2021
18.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022-2032
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Therapy Type
18.3.3. By Indication
18.3.4. By Dosage Form
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Therapy Type
18.4.3. By Indication
18.4.4. By Dosage Form
18.4.5. By End User
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Middle East and Africa Hormone Replacement Therapy Market 2017-2021 and Forecast 2022-2032
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017-2021
19.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022-2032
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. South Africa
19.3.1.3. Turkey
19.3.1.4. Rest of Middle East and Africa
19.3.2. By Therapy Type
19.3.3. By Indication
19.3.4. By Dosage Form
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Therapy Type
19.4.3. By Indication
19.4.4. By Dosage Form
19.4.5. By End User
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. Country Level Hormone Replacement Therapy Market Analysis and Forecast 2021 & 2031
20.1. Introduction
20.1.1. Market Value Proportion Analysis
20.1.2. Global VS. Country Growth Comparison
20.2. U.S. Hormone Replacement Therapy Market Analysis
20.2.1. By Therapy Type
20.2.2. By Indication
20.2.3. By Dosage Form
20.2.4. By End User
20.3. Canada Hormone Replacement Therapy Market Analysis
20.3.1. By Therapy Type
20.3.2. By Indication
20.3.3. By Dosage Form
20.3.4. By End User
20.4. Mexico Hormone Replacement Therapy Market Analysis
20.4.1. By Therapy Type
20.4.2. By Indication
20.4.3. By Dosage Form
20.4.4. By End User
20.5. Brazil Hormone Replacement Therapy Market Analysis
20.5.1. By Therapy Type
20.5.2. By Indication
20.5.3. By Dosage Form
20.5.4. By End User
20.6. Argentina Hormone Replacement Therapy Market Analysis
20.6.1. By Therapy Type
20.6.2. By Indication
20.6.3. By Dosage Form
20.6.4. By End User
20.7. Germany Hormone Replacement Therapy Market Analysis
20.7.1. By Therapy Type
20.7.2. By Indication
20.7.3. By Dosage Form
20.7.4. By End User
20.8. Italy Hormone Replacement Therapy Market Analysis
20.8.1. By Therapy Type
20.8.2. By Indication
20.8.3. By Dosage Form
20.8.4. By End User
20.9. France Hormone Replacement Therapy Market Analysis
20.9.1. By Therapy Type
20.9.2. By Indication
20.9.3. By Dosage Form
20.9.4. By End User
20.10. U.K. Hormone Replacement Therapy Market Analysis
20.10.1. By Therapy Type
20.10.2. By Indication
20.10.3. By Dosage Form
20.10.4. By End User
20.11. Spain Hormone Replacement Therapy Market Analysis
20.11.1. By Therapy Type
20.11.2. By Indication
20.11.3. By Dosage Form
20.11.4. By End User
20.12. BENELUX Hormone Replacement Therapy Market Analysis
20.12.1. By Therapy Type
20.12.2. By Indication
20.12.3. By Dosage Form
20.12.4. By End User
20.13. Russia Hormone Replacement Therapy Market Analysis
20.13.1. By Therapy Type
20.13.2. By Indication
20.13.3. By Dosage Form
20.13.4. By End User
20.14. China Hormone Replacement Therapy Market Analysis
20.14.1. By Therapy Type
20.14.2. By Indication
20.14.3. By Dosage Form
20.14.4. By End User
20.15. Japan Hormone Replacement Therapy Market Analysis
20.15.1. By Therapy Type
20.15.2. By Indication
20.15.3. By Dosage Form
20.15.4. By End User
20.16. South Korea Hormone Replacement Therapy Market Analysis
20.16.1. By Therapy Type
20.16.2. By Indication
20.16.3. By Dosage Form
20.16.4. By End User
20.17. India Hormone Replacement Therapy Market Analysis
20.17.1. By Therapy Type
20.17.2. By Indication
20.17.3. By Dosage Form
20.17.4. By End User
20.18. Indonesia Hormone Replacement Therapy Market Analysis
20.18.1. By Therapy Type
20.18.2. By Indication
20.18.3. By Dosage Form
20.18.4. By End User
20.19. Thailand Hormone Replacement Therapy Market Analysis
20.19.1. By Therapy Type
20.19.2. By Indication
20.19.3. By Dosage Form
20.19.4. By End User
20.20. Malaysia Hormone Replacement Therapy Market Analysis
20.20.1. By Therapy Type
20.20.2. By Indication
20.20.3. By Dosage Form
20.20.4. By End User
20.21. Australia and New Zealand Hormone Replacement Therapy Market Analysis
20.21.1. By Therapy Type
20.21.2. By Indication
20.21.3. By Dosage Form
20.21.4. By End User
20.22. New Zealand Hormone Replacement Therapy Market Analysis
20.22.1. By Therapy Type
20.22.2. By Indication
20.22.3. By Dosage Form
20.22.4. By End User
20.23. GCC Countries Hormone Replacement Therapy Market Analysis
20.23.1. By Therapy Type
20.23.2. By Indication
20.23.3. By Dosage Form
20.23.4. By End User
20.24. Turkey Hormone Replacement Therapy Market Analysis
20.24.1. By Therapy Type
20.24.2. By Indication
20.24.3. By Dosage Form
20.24.4. By End User
20.25. South Africa Hormone Replacement Therapy Market Analysis
20.25.1. By Therapy Type
20.25.2. By Indication
20.25.3. By Dosage Form
20.25.4. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Eli Lilly and Company
22.3.1.1. Overview & Key Financials
22.3.1.2. Therapy Type Portfolio
22.3.1.3. Sales Footprint
22.3.1.4. SWOT Analysis
22.3.1.5. Strategy
22.3.1.5.1. Marketing Strategy
22.3.1.5.2. Channel Strategy
22.3.2. Pfizer, Inc.
22.3.2.1. Overview & Key Financials
22.3.2.2. Therapy Type Portfolio
22.3.2.3. Sales Footprint
22.3.2.4. SWOT Analysis
22.3.2.5. Strategy
22.3.2.5.1. Marketing Strategy
22.3.2.5.2. Channel Strategy
22.3.3. AbbVie, Inc.
22.3.3.1. Overview & Key Financials
22.3.3.2. Therapy Type Portfolio
22.3.3.3. Sales Footprint
22.3.3.4. SWOT Analysis
22.3.3.5. Strategy
22.3.3.5.1. Marketing Strategy
22.3.3.5.2. Channel Strategy
22.3.4. Novo Nordisk A/S
22.3.4.1. Overview & Key Financials
22.3.4.2. Therapy Type Portfolio
22.3.4.3. Sales Footprint
22.3.4.4. SWOT Analysis
22.3.4.5. Strategy
22.3.4.5.1. Marketing Strategy
22.3.4.5.2. Channel Strategy
22.3.5. Merck KGaA
22.3.5.1. Overview & Key Financials
22.3.5.2. Therapy Type Portfolio
22.3.5.3. Sales Footprint
22.3.5.4. SWOT Analysis
22.3.5.5. Strategy
22.3.5.5.1. Marketing Strategy
22.3.5.5.2. Channel Strategy
22.3.6. Mylan N.V. (Viatris)
22.3.6.1. Overview & Key Financials
22.3.6.2. Therapy Type Portfolio
22.3.6.3. Sales Footprint
22.3.6.4. SWOT Analysis
22.3.6.5. Strategy
22.3.6.5.1. Marketing Strategy
22.3.6.5.2. Channel Strategy
22.3.7. Bayer Healthcare
22.3.7.1. Overview & Key Financials
22.3.7.2. Therapy Type Portfolio
22.3.7.3. Sales Footprint
22.3.7.4. SWOT Analysis
22.3.7.5. Strategy
22.3.7.5.1. Marketing Strategy
22.3.7.5.2. Channel Strategy
22.3.8. F. Hoffmann-La Roche Ltd.
22.3.8.1. Overview & Key Financials
22.3.8.2. Therapy Type Portfolio
22.3.8.3. Sales Footprint
22.3.8.4. SWOT Analysis
22.3.8.5. Strategy
22.3.8.5.1. Marketing Strategy
22.3.8.5.2. Channel Strategy
22.3.9. Teva Pharmaceuticals
22.3.9.1. Overview & Key Financials
22.3.9.2. Therapy Type Portfolio
22.3.9.3. Sales Footprint
22.3.9.4. SWOT Analysis
22.3.9.5. Strategy
22.3.9.5.1. Marketing Strategy
22.3.9.5.2. Channel Strategy
22.3.10. Endo International
22.3.10.1. Overview & Key Financials
22.3.10.2. Therapy Type Portfolio
22.3.10.3. Sales Footprint
22.3.10.4. SWOT Analysis
22.3.10.5. Strategy
22.3.10.5.1. Marketing Strategy
22.3.10.5.2. Channel Strategy
22.3.11. Sun Pharmaceutical Industries Ltd
22.3.11.1. Overview & Key Financials
22.3.11.2. Therapy Type Portfolio
22.3.11.3. Sales Footprint
22.3.11.4. SWOT Analysis
22.3.11.5. Strategy
22.3.11.5.1. Marketing Strategy
22.3.11.5.2. Channel Strategy
22.3.12. Tolmar Pharmaceuticals, Inc.
22.3.12.1. Overview & Key Financials
22.3.12.2. Therapy Type Portfolio
22.3.12.3. Sales Footprint
22.3.12.4. SWOT Analysis
22.3.12.5. Strategy
22.3.12.5.1. Marketing Strategy
22.3.12.5.2. Channel Strategy
22.3.13. Novartis AG
22.3.13.1. Overview & Key Financials
22.3.13.2. Therapy Type Portfolio
22.3.13.3. Sales Footprint
22.3.13.4. SWOT Analysis
22.3.13.5. Strategy
22.3.13.5.1. Marketing Strategy
22.3.13.5.2. Channel Strategy
22.3.14. Upsher-Smith Laboratories Inc.
22.3.14.1. Overview & Key Financials
22.3.14.2. Therapy Type Portfolio
22.3.14.3. Sales Footprint
22.3.14.4. SWOT Analysis
22.3.14.5. Strategy
22.3.14.5.1. Marketing Strategy
22.3.14.5.2. Channel Strategy
22.3.15. SottoPelle
22.3.15.1. Overview & Key Financials
22.3.15.2. Therapy Type Portfolio
22.3.15.3. Sales Footprint
22.3.15.4. SWOT Analysis
22.3.15.5. Strategy
22.3.15.5.1. Marketing Strategy
22.3.15.5.2. Channel Strategy
22.3.16. Neuva Aesthetics
22.3.16.1. Overview & Key Financials
22.3.16.2. Therapy Type Portfolio
22.3.16.3. Sales Footprint
22.3.16.4. SWOT Analysis
22.3.16.5. Strategy
22.3.16.5.1. Marketing Strategy
22.3.16.5.2. Channel Strategy
22.3.17. Ascend Therapeutics
22.3.17.1. Overview & Key Financials
22.3.17.2. Therapy Type Portfolio
22.3.17.3. Sales Footprint
22.3.17.4. SWOT Analysis
22.3.17.5. Strategy
22.3.17.5.1. Marketing Strategy
22.3.17.5.2. Channel Strategy
